LoginRegister
    Job Alert: NIPER Hyderabad releases vacancies for Faculty Post, DetailsJob Alert: NIPER Hyderabad releases vacancies for Faculty Post, Details
    Roche gets USFDA clearance for cobas pro solutions for diagnostics labsRoche gets USFDA clearance for cobas pro solutions for diagnostics labs
    Novartis Cosentyx meets primary endpoint in patients with axial spondyloarthritisNovartis Cosentyx meets primary endpoint in patients with axial spondyloarthritis
    AstraZeneca Farxiga gets USFDA fast track designation for heart failureAstraZeneca Farxiga gets USFDA fast track designation for heart failure
    Diabetes Management: Sanofi, Abbott team up to integrate glucose sensing, insulin delivery technologiesDiabetes Management: Sanofi, Abbott team up to integrate glucose sensing, insulin delivery...
    Cadila Pharma bags ObserveNow Future of Workplace Award among 50 others in frayCadila Pharma bags ObserveNow Future of Workplace Award among 50 others in fray
    Lundbeck to acquire migraine drugmaker Alder BioPharma for USD 1.95 billionLundbeck to acquire migraine drugmaker Alder BioPharma for USD 1.95 billion
    Biogen Alzheimer drug Aducanumab failure wipes USD 18 billion from market valueBiogen Alzheimer drug Aducanumab failure wipes USD 18 billion from market value
    Purdue Pharma files for bankruptcy protection as part of opioid settlementPurdue Pharma files for bankruptcy protection as part of opioid settlement
    CDSCO apprises about the Continuity in validity of Written Confirmation Certificate for API consignments for ExportsCDSCO apprises about the Continuity in validity of Written Confirmation Certificate for API...
    Unichem Labs receives zero USFDA observations for Roha facilityUnichem Labs receives zero USFDA observations for Roha facility
    GSK gets USFDA nod for Nucala, only biologic to treat eosinophilic asthma in age group 6-11 yearGSK gets USFDA nod for Nucala, only biologic to treat eosinophilic asthma in age group 6-11 year
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X